ArticleFrontiers in oncology2026

Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern Spain.

Alejandro Falcón-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.